Publications by authors named "Xavier Yoon-Han Sim"
Transfus Apher Sci
October 2015
Article Synopsis
- A randomized trial compared filgrastim and pegfilgrastim for peripheral blood stem cell mobilization (PBSCM) in patients receiving cyclophosphamide, analyzing various timing for pegfilgrastim administration.
- Pegfilgrastim given on day 7 resulted in the highest mobilization success rate (70.8%), compared to daily filgrastim (63.6%) and pegfilgrastim on day 3 (47.6%).
- The study found multiple myeloma patients were more successful in mobilization than those with acute leukemia or lymphoma, while pegfilgrastim helped avoid excessive white blood cell increases compared to filgrastim, with no significant difference in recovery times for white blood
